指南与共识胸部儿科影像CTMRDRUS

囊性纤维化肺部影像学最新综述及面向呼吸科与放射科医生的推荐意见:来自「囊性纤维化影像管理」(MAESTRO)联盟

State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium.
指南 / 共识 · Eur Respir Rev · 2022-03-23

由意大利10家最大专科中心的21名囊性纤维化专家组成委员会,经系统文献复习评价167篇文章、5次RAND会议和投票(每条推荐至少80%同意)形成28条共识声明。委员会认为需国际指南规范影像检查时机与方式选择;胸片应用仍有争议,CT与MRI应常规用于监测,目前无证据支持肺超声监测。

要点

  • CT与MRI应常规用于监测囊性纤维化肺病。
  • 胸片在囊性纤维化肺病中的应用仍存争议。
  • 目前无证据支持肺超声用于监测囊性纤维化肺病。

核心结论

  • 需制定国际指南明确囊性纤维化肺病患者影像检查的适当时机与方式选择,时机与选择取决于临床情景、患者年龄、肺功能和治疗类型。
  • 尽管胸片应用普遍,但其在囊性纤维化肺病中的应用仍存争议。
  • CT与MRI均应常规用于监测囊性纤维化肺病。
  • 未来研究应关注CT和MRI的成像方案统一化。
  • 人工智能影像分析的引入可能通过提供快速可靠的定量结果评估疾病状态,进一步革新临床实践。

研究设计与样本

  • 由意大利10家最大专科中心的21名囊性纤维化专家组成委员会,包括各中心1名放射科医生和1名呼吸科医生。
  • 系统复习相关文献后,委员会评价167篇文章。
  • 举行5次RAND会议后由执行小组委员会制定共识声明,全体共识委员会投票批准28条主要声明。
  • 每条推荐声明须获得至少80%的选票方可通过。

诊断标准与关键数值

  • 推荐声明须获得至少80%的选票方可通过。
  • 共识委员会投票批准28条主要声明。

临床应用与阅片要点

  • CT与MRI应常规用于监测囊性纤维化肺病。
  • 胸片虽普遍使用,但其在囊性纤维化肺病中的应用仍存争议。
  • 目前无证据支持肺超声用于监测囊性纤维化肺病。
  • 影像检查时机与方式选择取决于临床情景、患者年龄、肺功能和治疗类型。

局限性

  • 原文指出需制定国际指南以明确囊性纤维化肺病患者影像检查的适当时机与方式选择。
  • 原文指出胸片在囊性纤维化肺病中的应用仍存争议。
  • 原文指出未来研究应关注CT和MRI的成像方案统一化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Imaging represents an important noninvasive means to assess cystic fibrosis (CF) lung disease, which remains the main cause of morbidity and mortality in CF patients. While the development of new imaging techniques has revolutionised clinical practice, advances have posed diagnostic and monitoring challenges. The authors aim to summarise these challenges and make evidence-based recommendations regarding imaging assessment for both clinicians and radiologists.

STUDY DESIGN: A committee of 21 experts in CF from the 10 largest specialist centres in Italy was convened, including a radiologist and a pulmonologist from each centre, with the overall aim of developing clear and actionable recommendations for lung imaging in CF. An a priori threshold of at least 80% of the votes was required for acceptance of each statement of recommendation.

RESULTS: After a systematic review of the relevant literature, the committee convened to evaluate 167 articles. Following five RAND conferences, consensus statements were developed by an executive subcommittee. The entire consensus committee voted and approved 28 main statements.

CONCLUSIONS: There is a need for international guidelines regarding the appropriate timing and selection of imaging modality for patients with CF lung disease; timing and selection depends upon the clinical scenario, the patient's age, lung function and type of treatment. Despite its ubiquity, the use of the chest radiograph remains controversial. Both computed tomography and magnetic resonance imaging should be routinely used to monitor CF lung disease. Future studies should focus on imaging protocol harmonisation both for computed tomography and for magnetic resonance imaging. The introduction of artificial intelligence imaging analysis may further revolutionise clinical practice by providing fast and reliable quantitative outcomes to assess disease status. To date, there is no evidence supporting the use of lung ultrasound to monitor CF lung disease.

来源:Eur Respir Rev,查看原文。版权归原作者所有。

引用

  1. Ciet, Bertolo, Ros, et al. State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the "iMAging managEment of cySTic fibROsis" (MAESTRO) consortium. Eur Respir Rev. 2022. PMID: 35321929. doi:10.1183/16000617.0173-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。